mk-8189
Showing 1 - 7 of 7
Schizophrenia Trial (MK-8189, Moxifloxacin, Placebo)
Not yet recruiting
- Schizophrenia
- MK-8189
- +2 more
- (no location specified)
May 30, 2023
Schizophrenia Trial in Garden Grove, Marlton (MK-8189, Placebo)
Active, not recruiting
- Schizophrenia
- MK-8189
- Placebo
-
Garden Grove, California
- +2 more
Jan 31, 2023
Hepatic Impairment Trial in Chula Vista, Miami (MK-8189)
Completed
- Hepatic Impairment
- MK-8189
-
Chula Vista, California
- +1 more
Nov 23, 2022
Alzheimer's Disease Trial in United States (MK-8189, Placebo)
Completed
- Alzheimer's Disease
- MK-8189
- Placebo
-
Santa Ana, California
- +7 more
Jan 19, 2023
Schizophrenia Trial in Glendale (MK-8189, Placebo, Background AAP Therapy)
Completed
- Schizophrenia
- MK-8189
- +2 more
-
Glendale, CaliforniaCalifornia Clinical Trials ( Site 0001)
Mar 2, 2021
Schizophrenia Trial in Worldwide (MK-8189, Risperidone, Placebo to MK-8189)
Recruiting
- Schizophrenia
- MK-8189
- +3 more
-
Bentonville, Arkansas
- +92 more
Jan 5, 2023
Schizophrenia, Acute Episode Trial in United States (MK-8189, Risperidone, Placebo matching MK-8189)
Completed
- Schizophrenia, Acute Episode
- MK-8189
- +3 more
-
Little Rock, Arkansas
- +27 more
Dec 6, 2018